Literature DB >> 25705883

Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.

Virginie Prod'Homme, Laurent Boyer, Nicholas Dubois, Aude Mallavialle, Patrick Munro, Xavier Mouska, Isabelle Coste, Robert Rottapel, Sophie Tartare-Deckert, Marcel Deckert.   

Abstract

Cherubism is a rare autoinflammatory bone disorder that is associated with point mutations in the SH3-domain binding protein 2 (SH3BP2) gene, which encodes the adapter protein 3BP2. Individuals with cherubism present with symmetrical fibro-osseous lesions of the jaw, which are attributed to exacerbated osteoclast activation and defective osteoblast differentiation. Although it is a dominant trait in humans, cherubism appears to be recessively transmitted in mice, suggesting the existence of additional factors in the pathogenesis of cherubism. Here, we report that macrophages from 3BP2-deficient mice exhibited dramatically reduced inflammatory responses to microbial challenge and reduced phagocytosis. 3BP2 was necessary for LPS-induced activation of signaling pathways involved in macrophage function, including SRC, VAV1, p38MAPK, IKKα/β, RAC, and actin polymerization pathways. Conversely, we demonstrated that the presence of a single Sh3bp2 cherubic allele and pathogen-associated molecular pattern (PAMP) stimulation had a strong cooperative effect on macrophage activation and inflammatory responses in mice. Together, the results from our study in murine genetic models support the notion that infection may represent a driver event in the etiology of cherubism in humans and suggest limiting inflammation in affected individuals may reduce manifestation of cherubic lesions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25705883      PMCID: PMC4396483          DOI: 10.1172/JCI71081

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Unresponsiveness of MyD88-deficient mice to endotoxin.

Authors:  T Kawai; O Adachi; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

2.  The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.

Authors:  Isabelle Foucault; Séverine Le Bras; Céline Charvet; Chéol Moon; Amnon Altman; Marcel Deckert
Journal:  Blood       Date:  2004-09-02       Impact factor: 22.113

Review 3.  Src and Syk kinases: key regulators of phagocytic cell activation.

Authors:  Giorgio Berton; Attila Mócsai; Clifford A Lowell
Journal:  Trends Immunol       Date:  2005-04       Impact factor: 16.687

Review 4.  The adapter 3BP2: how it plugs into leukocyte signaling.

Authors:  Marcel Deckert; Robert Rottapel
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation.

Authors:  M Deckert; S Tartare-Deckert; J Hernandez; R Rottapel; A Altman
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

6.  Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.

Authors:  Yasuyoshi Ueki; Chin-Yu Lin; Makoto Senoo; Takeshi Ebihara; Naoki Agata; Masahiro Onji; Yasunori Saheki; Toshihisa Kawai; Padma M Mukherjee; Ernst Reichenberger; Bjorn R Olsen
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

Review 7.  The many faces of ITAMs.

Authors:  David M Underhill; Helen S Goodridge
Journal:  Trends Immunol       Date:  2007-01-02       Impact factor: 16.687

Review 8.  Regulation of innate immunity by Rho GTPases.

Authors:  Gary M Bokoch
Journal:  Trends Cell Biol       Date:  2005-03       Impact factor: 20.808

9.  Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism.

Authors:  Teruhito Yoshitaka; Tomoyuki Mukai; Mizuho Kittaka; Lisa M Alford; Salome Masrani; Shu Ishida; Ken Yamaguchi; Motohiko Yamada; Noriyoshi Mizuno; Bjorn R Olsen; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  Cell Rep       Date:  2014-09-15       Impact factor: 9.423

10.  Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1.

Authors:  A Marijke Keestra; Maria G Winter; Josef J Auburger; Simon P Frässle; Mariana N Xavier; Sebastian E Winter; Anita Kim; Victor Poon; Mariëtta M Ravesloot; Julian F T Waldenmaier; Renée M Tsolis; Richard A Eigenheer; Andreas J Bäumler
Journal:  Nature       Date:  2013-03-31       Impact factor: 49.962

View more
  11 in total

1.  Investigating global gene expression changes in a murine model of cherubism.

Authors:  Tulika Sharma; Justin Cotney; Vijender Singh; Archana Sanjay; Ernst J Reichenberger; Yasuyoshi Ueki; Peter Maye
Journal:  Bone       Date:  2020-03-10       Impact factor: 4.398

2.  RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146.

Authors:  Yoshinori Matsumoto; Jose Larose; Oliver A Kent; Melissa Lim; Adele Changoor; Lucia Zhang; Yaryna Storozhuk; Xiaohong Mao; Marc D Grynpas; Feng Cong; Robert Rottapel
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

3.  Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.

Authors:  Mizuho Kittaka; Tetsuya Yoshimoto; Collin Schlosser; Robert Rottapel; Mikihito Kajiya; Hidemi Kurihara; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2019-10-24       Impact factor: 6.741

4.  Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.

Authors:  Tetsuya Yoshimoto; Tatsuhide Hayashi; Toshio Kondo; Mizuho Kittaka; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2018-05-22       Impact factor: 6.741

Review 5.  Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.

Authors:  Tomoyuki Mukai; Shunichi Fujita; Yoshitaka Morita
Journal:  Cells       Date:  2019-02-22       Impact factor: 6.600

6.  Cherubism as a systemic skeletal disease: evidence from an aggressive case.

Authors:  Anne Morice; Aline Joly; Manon Ricquebourg; Gérard Maruani; Emmanuel Durand; Louise Galmiche; Jeanne Amiel; Yoann Vial; Hélène Cavé; Kahina Belhous; Marie Piketty; Martine Cohen-Solal; Ariane Berdal; Corinne Collet; Arnaud Picard; Amelie E Coudert; Natacha Kadlub
Journal:  BMC Musculoskelet Disord       Date:  2020-08-21       Impact factor: 2.362

7.  Tlr2/4-Mediated Hyperinflammation Promotes Cherubism-Like Jawbone Expansion in Sh3bp2 (P416R) Knockin Mice.

Authors:  Yasuyuki Fujii; Nelson Monteiro; Shyam Kishor Sah; Homan Javaheri; Yasuyoshi Ueki; Zhichao Fan; Ernst J Reichenberger; I-Ping Chen
Journal:  JBMR Plus       Date:  2021-10-30

8.  Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells.

Authors:  Kazuyasu Chihara; Yuji Kato; Hatsumi Yoshiki; Kenji Takeuchi; Shigeharu Fujieda; Kiyonao Sada
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

9.  Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice.

Authors:  Akiko Nagasu; Tomoyuki Mukai; Masanori Iseki; Kyoko Kawahara; Shoko Tsuji; Hajime Nagasu; Yasuyoshi Ueki; Katsuhiko Ishihara; Naoki Kashihara; Yoshitaka Morita
Journal:  Cells       Date:  2019-04-30       Impact factor: 6.600

10.  Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice.

Authors:  Mizuho Kittaka; Tetsuya Yoshimoto; Collin Schlosser; Mikihito Kajiya; Hidemi Kurihara; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  JBMR Plus       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.